Yıl: 2022 Cilt: 12 Sayı: 1 Sayfa Aralığı: 9 - 25 Metin Dili: İngilizce DOI: 10.37094/adyujsci.1020171 İndeks Tarihi: 10-08-2022

A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies

Öz:
Schiff base derivatives are some of the most widely used organic compounds for industrial purposes and they exhibit a broad range of biological activities. In this paper, a new Schiff base derivative (2) synthesized from the condensation reaction of 1-amino-5-benzoyl)-4- phenylpyrimidine-2(1H)-thione (1) with 2-chlorobenzaldehyde. The new compound was characterized by 1H, 13C NMR, and FT-IR. The biological activity property of this compound was tested against two different cancer cell lines and a healthy human cell line. The results demonstrate that molecule 2 has antiproliferative activity. In molecular modeling studies, the interaction site was examined using the epidermal growth factor receptor (EGFR) tyrosine kinase domain. Alignment in molecular docking, surface mapping binding, amino acids, and binding energy calculated. Glide score energy was found to be -9.820 kcal/mol and it predicted that the bonding interaction is strong. Theoretical calculations were made to compare the experimental and theoretical data. These calculations were performed on the 6–31 G* basis set using the Density Functional Theory (DFT) method and Becke-3-Parameter-Lee-Yang-Parr (B3LYP). Using this method, various parameters, such as frontier molecular orbitals, HOMO-LUMO energy levels, band gap, and chemical reactivity indices were found and interpreted.
Anahtar Kelime: Molecular Docking 2-Chlorobenzaldehyde Pyrimidine-2-thione Schiff Base Synthesis Cytotoxic activity

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Bogert, M.T., Beal, G.D., Researches on quinazolines (twenty-ninth paper). A further study of the stilbazoles, hydrazones and schiff bases of the 4-quinazolone group1, Journal of the American Chemical Society, 34, 516-524, 1912.
  • [2] Sumerford, W.T., Hartung, W.H., Jenkins, G.L., Some Schiff Bases with p- Aminothymol, Journal of the American Chemical Society, 62, 2082-2083, 1940.
  • [3] McIntire, F.C., Some Schiff bases of free amino acids, Journal of the American Chemical Society, 69, 1377-1380, 1947.
  • [4] Stephens, F.F., Heterocyclic compounds from Schiff's bases, Nature, 164, 243, 1949.
  • [5] Holly, F.W., Cope, A.C., Condensation products of aldehydes and ketones with o- aminobenzyl alcohol and o-hydroxybenzylamine, Journal of the American Chemical Society, 66, 1875-1879, 1944.
  • [6] Surrey, A.R., The preparation of 4-thiazolidones by the reaction of thioglycolic acid with Schiff bases, Journal of the American Chemical Society, 69, 2911-2912, 1947.
  • [7] Hodnett, E.M., Dunn, W.J., Structure-antitumor activity correlation of some Schiff bases, Journal of Medicinal Chemistry, 13, 768-770, 1970.
  • [8] Kaur, H., Lim, S.M., Ramasamy, K., Vasudevan, M., Shah, S.A.A., Narasimhan, B., Diazenyl schiff bases: Synthesis, spectral analysis, antimicrobial studies and cytotoxic activity on human colorectal carcinoma cell line (HCT-116), Arabian Journal of Chemistry, 13, 377-392, 2020.
  • [9] Ma, L.Y., Pang, L.P., Wang, B., Zhang, M., Hu, B., Xue, D.Q., Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents, European Journal of Medicinal Chemistry, 86, 368-380, 2014.
  • [10] Rai, D., Chen W Fau - Tian, Y., Tian Y Fau - Chen, X., Chen X Fau - Zhan, P., Zhan P Fau - De Clercq, E., De Clercq E Fau - Pannecouque, C., Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs, Bioorganic & Medicinal Chemistry, 21, 7398-7405, 2013.
  • [11] Ramiz, M.M.M., El-Sayed, W.A., El-Tantawy, A.I., Abdel-Rahman, A.A.H., Antimicrobial Activity of New 4,6-Disubstituted Pyrimidine, Pyrazoline, and Pyran Derivatives, Archives of Pharmacal Research, 33, 647-654, 2010.
  • [12] Hwang, J.Y., Windisch, M.P., Jo, S., Kim, K., Kong, S., Kim, H.C., Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor, Bioorganic & Medicinal Chemistry Letters, 22, 7297-7301, 2012.
  • [13] Gondkar, A.S., Deshmukh, V.K., Chaudhari, S.R., Synthesis, characterization and in- vitro anti-inflammatory activity of some substituted 1,2,3,4 tetrahydropyrimidine derivatives, Drug Invention Today, 5, 175-181, 2013.
  • [14] Onal, Z., Daylan, A.C., Cyclization reactions of 1-pyrimidinyl-3-arylthiourea derivatives with oxalyl dichlorideAsian Journal of Chemistry, 19, 1455-1460, 2007.
  • [15] Saracoglu, M., Kokbudak, Z., Yalcin, E., Kandemirli, F., Synthesis and Dft quantum chemical calculations of 2-oxopyrimidin-1(2h)-yl-urea and thiorea derivatives, Journal of The Chemical Society of Pakistan, 41, 841-858, 2019.
  • [16] Onal, Z., Ceran, H., Sahin, E., Synthesis of novel dihydropyrazolo[1,5-C]pyrimidin- 7(3h)-one/-thione derivatives, Heterocyclic Communications, 14, 245-250, 2008.
  • [17] Cimen, Z., Akkoc, S., Kokbudak, Z. Reactions of aminopyrimidine derivatives with chloroacetyl and isophthaloyl chlorides, Heteroatom Chemistry, 29, 2018.
  • [18] Aslan, H.G., Akkoc, S., Kokbudak, Z., Aydin, L., Synthesis, characterization, and antimicrobial and catalytic activity of a new Schiff base and its metal(II) complexes, Journal of the Iranian Chemical Society, 14, 2263-2273, 2017.
  • [19] Aslan, H.G., Akkoc, S., Kokbudak, Z., Anticancer activities of various new metal complexes prepared from a Schiff base on A549 cell line, Inorganic Chemistry Communications, 111, 2020
  • [20] Kokbudak, Z., Saracoglu, M., Akkoc, S., Cimen, Z., Yilmazer, M.I., Kandemirli, F., Synthesis, cytotoxic activity and quantum chemical calculations of new 7-thioxopyrazolo[1,5- f]pyrimidin-2-one derivatives. Journal of Molecular Structure, 1202, 2020.
  • [21] Kokbudak, Z., Aslan, H.G., Akkoc, S., New Schiff Bases Based on 1-Aminopyrimidin- 2-(1h)-One: Design, Synthesis, Characterization and Theoretical Calculations, Heterocycles, 100, 440-449, 2020.
  • [22] Elmaci, G., Duyar, H., Aydiner, B., Seferoglu, N., Naziri, M.A., Sahin, E., The syntheses, molecular structure analyses and DFT studies on new benzil monohydrazone based Schiff bases, Journal of Molecular Structure, 1162, 37-44, 2018.
  • [23] Elmaci, G., Duyar, H., Aydiner, B., Yahaya, I., Seferoglu, N., Sahin, E., Novel benzildihydrazone based Schiff bases: Syntheses, characterization, thermal properties, theoretical DFT calculations and biological activity studies, Journal of Molecular Structure, 1184, 271-280, 2019.
  • [24] Elmacı, G., Aktan, E., Seferoğlu, N., Hökelek, T., Seferoğlu, Z., Synthesis, molecular structure and computational study of (Z)-2-((E)-4-nitrobenzylidene) hydrazone)-1, 2- diphenylethan-1-one, Journal of Molecular Structure, 1099, 83-91, 2015.
  • [25] Antonello, A., Tarozzi, A., Morroni, F., Cavalli, A., Rosini, M., Hrelia, P., Multitarget- directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects, Journal of Medicinal Chemistry, 49, 6642- 6645, 2006.
  • [26] Pawar, V.G., Sos, M.L., Rode, H.B., Rabiller, M., Heynck, S., van Otterlo, W.A.L., Synthesis and Biological Evaluation of 4-Anilinoquinolines as Potent Inhibitors of Epidermal Growth Factor Receptor, Journal of Medicinal Chemistry, 53, 2892-2901, 2010.
  • [27] Yu, H.Q., Li, Y.X., Ge, Y., Song, Z.D., Wang, C.Y., Huang, S.S., Novel 4- anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines, European Journal of Medicinal Chemistry, 110, 195- 203, 2016.
  • [28] Elbastawesy, M.A.I., Aly, A.A., Ramadan, M., Elshaier, Y.A.M.M., Youssif, B.G.M., Brown, A.B., Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors, Bioorganic Chemistry, 90, 103045, 2019.
  • [29] Zhang, Y.L., Chen, L., Li, X.B., Gao, L., Hao, Y.X., Li, B.L., Novel 4- arylaminoquinazolines bearing N,N-diethyl(aminoethyl)amino moiety with antitumour activity as EGFR(wt)-TK inhibitor, Journal of Enzyme Inhibition and Medicinal Chemistry, 34, 1668-1677, 2019.
  • [30] Zhang, Y.L., Chen, L., Xu, H.J., Li, X.B., Zhao, L.J., Wang, W., 6,7- Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells, European Journal of Medicinal Chemistry, 147, 77-89, 2018.
  • [31] Abbas, H.A.S., Abd El Karim, S.S., Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents, Bioorganic Chemistry, 89, 103035, 2019.
  • [32] Guardiola, S., Varese, M., Sanchez-Navarro, M., Giralt, E. A Third Shot at EGFR: New Opportunities in Cancer Therapy. Trends Pharmacol Sci. 2019, 40, 941-55.
  • [33] Leonetti, A., Assaraf, Y.G., Veltsista, P.D., El Hassouni, B., Tiseo, M., Giovannetti, E., MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions, Drug Resistance Update, 42, 1-11, 2019.
  • [34] Rolfo, C., Giovannetti, E., Hong, D.S., Bivona, T., Raez, L.E., Bronte, G., Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors, Cancer Treatment Reviews, 40, 990-1004, 2014.
  • [35] Piotrowska, Z., Sequist, L.V., Treatment of EGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors A Review, Jama Oncology, 2, 948-954, 2016.
  • [36] Recondo, G., Facchinetti, F., Olaussen, K.A., Besse, B., Friboulet, L., Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI. Nature Reviews Clinical Oncology, 15, 694-708, 2018.
  • [37] Akkoç, S., Derivatives of 1-(2-(Piperidin-1-yl)ethyl)-1H-benzo[d]imidazole: Synthesis, Characterization, Determining of Electronic Properties and Cytotoxicity Studies, ChemistrySelect, 4, 4938-43, 2019.
  • [38] Akkoç, S., Antiproliferative activities of 2-hydroxyethyl substituted benzimidazolium salts and their palladium complexes against human cancerous cell lines, Synthetic Communications, 49, 2903-2914, 2019.
  • [39] Bozbey, I., Uslu, H., Türkmenoğlu, B., Özdemir, Z., Karakurt, A., Levent, S., Conventional and microwave prompted synthesis of aryl (alkyl) azole oximes, 1H-NMR spectroscopic determination of E/Z isomer ratio and HOMO-LUMO analysis, Journal of Molecular Structure, 1251, 132077, 2022.
  • [40] Wavefunction, I. Spartan'08. Irvine, CA. 1991, 2009.
  • [41] Lukovits, I., Bakó, I., Shaban, A., Kálmán, E. Polynomial model of the inhibition mechanism of thiourea derivatives, Electrochimica Acta, 43, 131-6, 1998.
  • [42] Parr, R.G., Pearson, R.G. Absolute hardness: companion parameter to absolute electronegativity, Journal of the American Chemical Society, 105, 7512-6, 1983.
  • [43] Parr, R.G., Donnelly, R.A., Levy, M., Palke, W.E. Electronegativity: the density functional viewpoint, The Journal of Chemical Physics, 68, 3801-7, 1978.
  • [44] Parr, R.G., Chattaraj, P.K. Principle of maximum hardness. Journal of the American Chemical Society, 113, 1854-5, 1991.
  • [45] Parr, R.G., Szentpály, L.v., Liu, S. Electrophilicity index, Journal of the American Chemical Society, 121, 1922-1924, 1999.
  • [46] Oladipo, S.D., Yusuf, T.L., Zamisa, S.J., Shapi, M., Ajayi, T.J. Synthesis, crystal structure, Hirshfeld surface analysis and DFT studies of N-(2,6-diisopropylphenyl)-1-(4- methoxyphenyl) methanimine, Journal of Molecular Structure, 1241, 13620, 2021.
  • [47] Schrödinger Release 2021-2: Glide, S., LLC, New York, NY, 2021.
  • [48] Anil, D.A., Aydin, B.O., Demir, Y., Turkmenoglu, B., Design, Synthesis, Biological Evaluation and Molecular Docking Studies of Novel 1H-1, 2, 3-Triazole Derivatives as Potent Inhibitors of Carbonic Anhydrase, Acetylcholinesterase and Aldose Reductase, Journal of Molecular Structure,132613, 2022.
  • [49] Schrödinger Release 2021-2: Protein Preparation Wizard; Epik, S., LLC, New York, NY, 2021; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY, 2021.
  • [50] Schrödinger Release 2021-2: LigPrep, S., LLC, New York, NY, 2021.
  • [51] Schrödinger Release 2021-2: Qikprop, L., New York, NY, 2021.
  • [52] Kökbudak, Z., Akkoç, S., Karataş, H., Tüzün, B., Aslan, G., In Silico and In Vitro Antiproliferative Activity Assessment of New Schiff Bases, Chemistryselect, 7, e202103679, 2022.
  • [53] Devim, M., Akkoç, S., Zeyrek, C.T., Aslan, H.G., Kökbudak, Z., Design, synthesis, in vitro antiproliferative activity properties, quantum chemical and molecular docking studies of novel Schiff bases incorporating pyrimidine nucleus, Journal of Molecular Structure, 132421, 2022.
  • [54] Vagish, C.B., Kumara, K., Vivek, H.K., Bharath, S., Lokanath, N.K., Kumar, K.A. Coumarin-triazole hybrids: Design, microwave-assisted synthesis, crystal and molecular structure, theoretical and computational studies and screening for their anticancer potentials against PC-3 and DU-145, Journal of Molecular Structure, 1230, 2021.
  • [55] Lewis, D.F.V., Ioannides, C., Parke, D.V., Interaction of a Series of Nitriles with the Alcohol-Inducible Isoform of P450 - Computer-Analysis of Structure-Activity-Relationships, Xenobiotica, 24, 401-408, 1994.
  • [56] Sheela, N.R., Muthu, S., Sampathkrishnan, S., Molecular orbital studies (hardness, chemical potential and electrophilicity), vibrational investigation and theoretical NBO analysis of 4-4 '-(1H-1,2,4-triazol-1-yl methylene) dibenzonitrile based on abinitio and DFT methods, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 20, 237-251, 2014.
  • [57] Sallam, H.H., Mohammed, Y.H.I., Al-Ostoot, F.H., M. A, S., Khanum, S.A., Synthesis, crystal structure characterization, DFT calculations, Hirshfeld surface analysis and 3D energy frameworks of triazole pyridazine derivatives: Theoretical and experimental studies, Journal of Molecular Structure, 1246, 131242, 2021.
  • [58] Benbouguerra, K., Chafai, N., Chafaa, S., Touahria, Y.I., Tlidjane, H., New alpha- Hydrazinophosphonic acid: Synthesis, characterization, DFT study and in silico prediction of its potential inhibition of SARS-CoV-2 main protease, Journal of Molecular Structure, 1239, 130480, 2021.
  • [59] Domingo, L.R., Aurell, M.J., Perez, P., Contreras, R., Quantitative characterization of the global electrophilicity power of common diene/dienophile pairs in Diels-Alder reactions, Tetrahedron, 58, 4417-4423, 2002.
APA KÖKBUDAK Z, TÜRKMENOĞLU B, Akkoç S (2022). A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. , 9 - 25. 10.37094/adyujsci.1020171
Chicago KÖKBUDAK ZÜLBİYE,TÜRKMENOĞLU BURÇİN,Akkoç Senem A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. (2022): 9 - 25. 10.37094/adyujsci.1020171
MLA KÖKBUDAK ZÜLBİYE,TÜRKMENOĞLU BURÇİN,Akkoç Senem A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. , 2022, ss.9 - 25. 10.37094/adyujsci.1020171
AMA KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. . 2022; 9 - 25. 10.37094/adyujsci.1020171
Vancouver KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. . 2022; 9 - 25. 10.37094/adyujsci.1020171
IEEE KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S "A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies." , ss.9 - 25, 2022. 10.37094/adyujsci.1020171
ISNAD KÖKBUDAK, ZÜLBİYE vd. "A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies". (2022), 9-25. https://doi.org/10.37094/adyujsci.1020171
APA KÖKBUDAK Z, TÜRKMENOĞLU B, Akkoç S (2022). A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. Adıyaman Üniversitesi Fen Bilimleri Dergisi, 12(1), 9 - 25. 10.37094/adyujsci.1020171
Chicago KÖKBUDAK ZÜLBİYE,TÜRKMENOĞLU BURÇİN,Akkoç Senem A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. Adıyaman Üniversitesi Fen Bilimleri Dergisi 12, no.1 (2022): 9 - 25. 10.37094/adyujsci.1020171
MLA KÖKBUDAK ZÜLBİYE,TÜRKMENOĞLU BURÇİN,Akkoç Senem A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. Adıyaman Üniversitesi Fen Bilimleri Dergisi, vol.12, no.1, 2022, ss.9 - 25. 10.37094/adyujsci.1020171
AMA KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. Adıyaman Üniversitesi Fen Bilimleri Dergisi. 2022; 12(1): 9 - 25. 10.37094/adyujsci.1020171
Vancouver KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies. Adıyaman Üniversitesi Fen Bilimleri Dergisi. 2022; 12(1): 9 - 25. 10.37094/adyujsci.1020171
IEEE KÖKBUDAK Z,TÜRKMENOĞLU B,Akkoç S "A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies." Adıyaman Üniversitesi Fen Bilimleri Dergisi, 12, ss.9 - 25, 2022. 10.37094/adyujsci.1020171
ISNAD KÖKBUDAK, ZÜLBİYE vd. "A New Schiff Base Molecule Prepared from Pyrimidine-2-thione: Synthesis, Spectral Characterization, Cytotoxic Activity, DFT, and Molecular Docking Studies". Adıyaman Üniversitesi Fen Bilimleri Dergisi 12/1 (2022), 9-25. https://doi.org/10.37094/adyujsci.1020171